J. Mitty

M. A. Murphy, J. Mitty, Erica M Szabados, 2007, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

Differences in Attitudes About HIV Pre-Exposure Prophylaxis Use Among Stimulant Versus Alcohol Using Men Who Have Sex with Men

M. Mimiaga, K. Mayer, S. Safren, 2016, AIDS and Behavior.

The feasibility of modified directly observed therapy for HIV-seropositive African American substance users.

J. Mitty, J. Kibler, M. Coleman, 2008, AIDS patient care and STDs.

Addressing the need for treatment paradigms for drug-abusing patients with multiple morbidities.

T. Flanigan, J. Mitty, J. Khalsa, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Use of community-based, directly observed therapy for HIV infection: lessons learned for treatment of hepatitis C virus infection.

L. Taylor, T. Flanigan, J. Mitty, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Community-based interventions for marginalized populations.

T. Flanigan, J. Mitty, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Epidemiology, clinical manifestations, and diagnosis of Cryptococcus neoformans meningoencephalitis in HIV-infected patients Authors

J. Bartlett, G. Cox, J. Mitty, 2016 .

Once-daily therapies for the treatment of HIV infection

K. Tashima, J. Mitty, 2006, Current HIV/AIDS reports.

Perspectives on HIV prevention among urban black women: a potential role for HIV pre-exposure prophylaxis.

Charlene A Flash, M. Mimiaga, V. Stone, 2014, AIDS patient care and STDs.

Modified directly observed therapy for the treatment of HIV-seropositive substance users: lessons learned from a pilot study.

T. Flanigan, J. Mitty, G. Macalino, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Exploring strategies for PrEP adherence and dosing preferences in the context of sexualized recreational drug use among MSM: a qualitative study

M. Mimiaga, K. Mayer, Elizabeth F. Closson, 2018, AIDS care.

Sexual Partnerships and Considerations for HIV Antiretroviral Pre-Exposure Prophylaxis Utilization Among High-Risk Substance Using Men Who Have Sex with Men

M. Mimiaga, Elizabeth F. Closson, J. Mitty, 2013, Archives of Sexual Behavior.

The “Safe Sex” Conundrum: Anticipated Stigma From Sexual Partners as a Barrier to PrEP Use Among Substance Using MSM Engaging in Transactional Sex

M. Mimiaga, K. Mayer, S. Safren, 2016, AIDS and Behavior.

Limited Awareness and Low Immediate Uptake of Pre-Exposure Prophylaxis among Men Who Have Sex with Men Using an Internet Social Networking Site

M. Mimiaga, J. Rosenberger, K. Mayer, 2012, PloS one.

Knowledge, Beliefs and Practices Regarding Antiretroviral Medications for HIV Prevention: Results from a Survey of Healthcare Providers in New England

I. Wilson, K. Mayer, J. Mitty, 2015, PloS one.

Linkage to Treatment and Supportive Services Among HIV-Positive Ex-Offenders in Project Bridge

J. Rich, C. Beckwith, T. Flanigan, 2008, Journal of health care for the poor and underserved.

Sexual Partnerships and Considerations for HIV Antiretroviral Pre-Exposure Prophylaxis Utilization Among High-Risk Substance Using Men Who Have Sex with Men

M. Mimiaga, Elizabeth F. Closson, J. Mitty, 2014, Archives of sexual behavior.

Decrease in the proportion of injecting drug use-related HIV/AIDS in Massachusetts, New York, Connecticut, and Rhode Island.

J. Rich, C. Beckwith, J. Mitty, 2008, The AIDS reader.

Participant Characteristics and HIV Risk Behaviors Among Individuals Entering Integrated Buprenorphine/Naloxone and HIV Care

T. Flanigan, J. Mitty, D. Fiellin, 2011, Journal of acquired immune deficiency syndromes.

Extending treatment for HCV infection to HIV-HCV coinfected individuals with psychiatric illness and drug dependence.

L. Taylor, S. Allen, J. Mitty, 2003, Clinical Infectious Diseases.

HIV infection in refugees: a case-control analysis of refugees in Rhode Island.

C. Beckwith, J. Mitty, S. Cu-Uvin, 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherence

A. Caliendo, T. Flanigan, J. Mitty, 2003, AIDS.

Enhancing adherence to HAART: a pilot program of modified directly observed therapy.

T. Flanigan, J. Mitty, M. Stenzel, 2001, The AIDS reader.

Attitudes and perceptions of AIDS clinical trials group site coordinators on HIV clinical trial recruitment and retention: a descriptive study.

M. Fischl, W. King, J. Mitty, 2007, AIDS patient care and STDs.

The 2010 Health Care Act and barriers to effective health promotion among men who have sex with men.

K. Mayer, J. Mitty, H. Makadon, 2012, Sexually transmitted diseases.

Applying behavioral activation to sustain and enhance the effects of contingency management for reducing stimulant use among individuals with HIV infection

M. Mimiaga, S. Safren, Elizabeth F. Closson, 2018, Psychology, health & medicine.

Directly observed therapy (DOT) for individuals with HIV: successes and challenges.

L. Taylor, T. Flanigan, J. Mitty, 2003, MedGenMed : Medscape general medicine.

Diseases from North America: focus on tick-borne infections.

J. Mitty, R. Nathavitharana, 2015, Clinical medicine.

The good, the bad, and the ugly: providing highly active antiretroviral therapy when it is most difficult.

T. Flanigan, J. Mitty, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Impact of Cocaine Use on Outcomes in HIV-Infected Patients Receiving Buprenorphine/Naloxone

J. Mitty, P. O'Connor, R. Schottenfeld, 2011, Journal of acquired immune deficiency syndromes.

Modified Directly Observed Therapy for Antiretroviral Therapy: A Primer from the Field

K. Goggin, Robin Liston, J. Mitty, 2007, Public health reports.

A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users

J. Hogan, A. Caliendo, T. Flanigan, 2007, AIDS.

Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure.

J. Caro, T. Flanigan, K. Melbourne, 2000, Clinical therapeutics.

Track C Epidemiology and Prevention Science

David R. Holtgrave, W. Heneine, Y. Nakamura, 2012, Journal of the International AIDS Society.

The Potential Use of Directly Observed Therapy (DOT) for the Treatment of HIV-positive Individuals Being Released From Prison

T. Flanigan, J. Mitty, L. Bazerman, 2005 .

Modified directly observed therapy: sustained self-reported adherence and HIV health status.

J. Mitty, L. Bazerman, Delphine Huang, 2007, AIDS patient care and STDs.

Opioid-Prescribing Practices and Provider Confidence Recognizing Opioid Analgesic Abuse in HIV Primary Care Settings

J. Mitty, D. Fiellin, J. Egan, 2011, Journal of acquired immune deficiency syndromes.

Participant Characteristics and HIV Risk Behaviors Among Individuals Entering Integrated Buprenorphine/Naloxone and HIV Care

T. Flanigan, J. Mitty, D. Fiellin, 2011, Journal of acquired immune deficiency syndromes.

The Impact of Cocaine Use on Outcomes in HIV-Infected Patients Receiving Buprenorphine/Naloxone

J. Mitty, P. O'Connor, R. Schottenfeld, 2011, Journal of acquired immune deficiency syndromes.

Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress.

V. Stone, T. Flanigan, J. Mitty, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.